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Background/Aims. To evaluate optic nerve head with spectral domain optical coherence tomography (OCT) in patients with Chiari
I malformation (CMI) compared to healthy controls. Methods. Cross-sectional study. OCT of the optic nerve head of 22 patients
with CMI and 22 healthy controls was quantitatively analyzed. The healthy controls were matched for age and sex with the study
population. Mean retinal nerve fiber layer (RNFL) thickness was calculated for both eyes; the mean thickness value was also
registered for each quadrant and for each subfield of the four quadrants. Results. CMI patients showed a reduction of the RNFL
thickness in both eyes.This reduction was more statistically significant (푃 < 0.05) for the inferior quadrant in the right eye and in
each quadrant than nasal one in the left eye. Conclusion. A distress of the retinal nerve fibers could explain the observed reduction
of the RNFL thickness in patients with CMI; in our series the reduction of the RNFL thickness seems lower when CMI is associated
with syringomyelia.
1. Introduction
Chiari I malformation (CMI) is a rare congenital disorder
recognized by caudal displacement of the cerebellar tonsils
through the foramen magnum and into the cervical canal
[1]. The mechanism for the development of the often asso-
ciated syringomyelia is attributed to partial obstruction of
the subarachnoid space at the foramen magnum due to
the pulsatile impaction of the tonsils [2, 3]. The complex
symptom patterns for CMI usually are late-onset and are
related to the presence of an associated syrinx and/or the
compression of neural structures at the cervicomedullary
junction by the herniated tonsils [4]. The most common
presenting symptom is suboccipital headache, which has
been reported in 81%of patients and is classically exacerbated
by Valsalva maneuvers [5]. Additional presenting symptoms
include ocular, otoneurological, brainstem, and spinal cord
disturbances [5]. Symptoms involving ocular function consist
of pseudotumor-like episodes of blurred vision, photophobia,
diplopia, retroorbital pain, and visual fields cuts and occur
in 78% of patients [5]. Despite the high percentage of this
association, the neuroophthalmological findings of patients
with CMI have not been extensively investigated in literature
and remain largely elusive. Looking at the ophthalmological
examination papilloedema is a rare but knownmanifestation
of CMI [5–10]. This study aimed to observe the RNFL
thickness through optical coherence tomography (OCT) in
a consecutive series of patients with CMI compared with a
control group.
2. Materials and Methods
Twenty-two patients who had been referred to neurosurgery
department for evaluation of CMI were investigated between
March 2011 and July 2012. Patients with any coexisting ocular
disease were excluded, but otherwise there was no patient
selection.
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Healthy controls were recruited from staff at the hospital;
people with known ophthalmologic or other neurologic
diseases were excluded.
The work was conducted in accordance with the Dec-
laration of Helsinki (1964) and the consents of the human
subjects were collected. Any ethical committee authorization
was necessary because of observational study. Complete
clinical and neuroradiological assessment was performed in
all patients. Neuroradiological investigation included mag-
netic resonance (MR) imaging of the cranial and spinal
compartments. To be eligible for the study, each patient was
required to have cerebellar tonsillar ectopia measured as≥5mm below a line connecting the basion and the opisthion
onMR images. Tonsillar ectopia was quantified bymeasuring
a line perpendicular to this line that extended to the most
inferior aspect of the cerebellar tonsils [11–13]. Additionally,
MR images were assessed for the presence of syringomyelia,
a chronic disease of the spinal cord characterized by the
presence of fluid-filled cavities and leading to spasticity and
sensory disturbances.
Syringomyelia is a dilatation caused by excessive cere-
brospinal fluid (CSF) accumulation within the central canal
or the extracanalicular area. Type 1 and 2 Chiari, the Dandy-
Walker syndrome, cerebellar ectopia, basilar impression,
basilar arachnoiditis, posterior fossa tumors and arachnoid
cysts, medulla spinalis tumors, spinal trauma, and infections
are among the pathologies that can cause syringomyelia.
There are also several idiopathic cases of syringomyelia.
Our study cohort consists of 22 patients and 22 healthy
controls. The healthy controls were matched for age and
sex with the study population and to be eligible for the
study the clinical, neuroradiological, and ophthalmological
examination should be negative for any known disease.
All the study population underwent clinical examination
which included ophthalmological evaluation, which con-
sisted of best corrected visual acuity (BCVA) and intraocular
pressure (IOP)measurement and fundus examination. BCVA
was registered using logarithm of the minimum angle of
resolution (LogMAR).
The Topcon 3DOCT 1000 (Topcon, Oakland, NJ, version
3.30) uses a superluminescent diode laser with a wavelength
of 840 nm as the light source. This system acquires 27,000
A-scans per second with axial resolution of ≤6 휇m. The
protocol used was the Glaucoma 3D 6.6mm, which includes
128 horizontal scans comprised of 512 A-scans. Only scans
with quality factor (Q-factor) ≥45 were accepted. After
creating a peripapillary RNFL thickness map from the cube
dataset in both devices, the software finds the optic disc and
automatically places a calculation circle 3.46mm in diameter
centered around the disc; the machine then extracts the peri-
papillary circle data from the cube dataset for RNFL thickness
measurement. Internal fixation was used for all subjects with
both devices and if fixation was not proper, an external
fixation target was applied in order to move the scanning
area to the appropriate location. Images with discontinuity
or misalignment, involuntary saccade, or blinking artifacts
were excluded. The RNFL thickness parameters that were
automatically calculated by the machines and investigated
in this study included average thickness, temporal, superior,
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Figure 1:The peripapillary area has been divided in four quadrants.
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Figure 2: The peripapillary area has been divided in 12 subfields,
three for each quadrant.
nasal, and inferior quadrant thicknesses, and three subfields
for each quadrant thicknesses (Figures 1 and 2).
Among the 22 patients, 19 patients with mild or absent
clinical symptoms were not considered for immediate sur-
gical treatment, whereas 3 symptomatic patients underwent
posterior fossa decompression, dura mater opening, and
duraplasty. In the surgical group, the first postoperative
clinical and neuroradiological examinations (MR) were per-
formed 3months after surgery.
Statistical analysis was performed using the Shapiro-
Wilk test to verify normality of distributions in order to
assess whether or not to use parametric tests. We used
the t-test to compare Gaussian distributions; otherwise we
performed the Mann-Whitney U test.The statistical analysis
was concluded with power tests (ex-post) to estimate the
sample sizes required for the study. The 1−훽 value of the
significant variables was >0.8, assuring a low risk of type II
error and an appropriate sample size. Data were entered into
an Excel database and were subsequently imported into the
software IBM SPSS Statistics 17.0.1.
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Table 1: CMI patients (Group A) versus healthy subject (Group C) OCT parameters, RE.
Variables Average (휇) Average (휇) 푃 value
Standard deviation Group A Standard deviation Group C
RNFL 102,750 (7,188) 108,500 (14,180) 0.158
Superior quadrant 130,813 (17,387) 127,688 (17,327) 0.614
Subfield 11 124,375 (20,314) 133,313 (20,959) 0.230
Subfield 12 139,000 (25,451) 129,813 (26,838) 0.328
Subfield 1 129,063 (23,809) 119,875 (26,339) 0.309
Nasal quadrant 94,000 (17,877) 96,500 (23,653) 0.738
Subfield 2 124,375 (20,314) 133,313 (20,959) 0.534
Subfield 3 139,000 (25,451) 129,813 (26,838) 0.759
Subfield 4 129,063 (23,809) 119,875 (26,339) 0.902
Inferior quadrant 115,438 (14,882) 129,688 (17,861) 0.020∗
Subfield 5 104,750 (17,935) 110,563 (32,307) 0.115
Subfield 6 80,313 (20,921) 82,500 (19,082) 0.142
Subfield 7 96,625 (21,713) 95,625 (23,872) 0.068
Temporal quadrant 94,000 (17,877) 96,500 (23,653) 0.454
Subfield 8 103,250 (27,560) 118,500 (25,612) 0.262
Subfield 9 121,688 (25,933) 135,750 (26,792) 0.118
Subfield 10 122,000 (16,959) 134,250 (19,608) 0.035∗
RNFL: retinal nerve fiber layer thickness in 휇.
Group A: patient with CMI.
Group C: healthy subjects.
1–12: three subfields for each quadrant numbered clockwise.∗푃 < 0.05, 푡-test.
3. Results
Twenty-two patients affected by CMI, ranging in age from
17 to 54 years (mean age, 35 years), were enrolled; 15
patients were women and 7 were men (3 : 1). Mean BCVA
was 0.0 LogMAR in both eyes, and mean IOP was normal,
respectively, 13.6 ± 2.6mmHg in right eye (RE) and 13.9 ± 2.6
mmHg in left eye (LE). At the fundus examination the ONH
appearance was normal in all patients except for 3 symp-
tomatic women that showed a papilloedema. In six of the
twenty-two patients at themagnetic resonance (MR) imaging
of the cranial and spinal compartments a syringomyelia was
detected; for this reason the patients were divided into two
groups, the first one with CMI alone (Group A, sixteen
patients) and the second group with CMI associated with
syringomyelia (Group B, six patients). None of the patients
complained from diplopia, and only two had blurry vision.
Twenty-two healthy individuals were included in the
study as controls. The mean age was 38 years (min 25;
max 52). BCVA was 0.0 LogMAR in all cases, and mean
IOP was, respectively, 14.2 ± 1.5mmHg in RE and 15.5 ±
2.1mmHg in LE (normal values < 21mmHg) comparable to
the group of patients. Fundus examination and OCT images
were unremarkable. As for the case group we divided the
controls into two groups (GroupC andGroupD)matched for
age and sex to the case groups. For each patient we considered
the OCT examination of the right eye and of the left one and
we compared it, respectively, with the right eye and the left
eye of the controls.
The mean RNFL thickness in CMI patients (Group A)
was more inferior than in control patients (Group C) with
a statistically significant reduction (푃 < 0.05) in the RE
in the inferior quadrant and in a subfield of the temporal
quadrant; in the left eye the reduction of the mean RNFL
thickness was significant and also in three of the four
quadrants (superior, temporal, and inferior) the reduction
was statistically significant (Tables 1 and 2).
Comparing Group B (CMI associated with syringomy-
elia) to the control group (GroupD) a smaller reduction of the
mean RNFL was observed but the difference was statistically
significant (푃 < 0.05) in the superior quadrant of the RE and
in the temporal quadrant of the LE; a statistically significant
(푃 < 0.05) difference was also observed in four subfields: one
in the RE and three in the LE (Tables 3 and 4).
From the comparison between patients with CMI (Group
A) and patients with CMI and syringomyelia (Group B) a sta-
tistically significant (푃 < 0.05) difference has been observed
for the mean RNFL thickness of the RE and in the inferior
quadrant of the LE, showing a higher value in Group B.
The three patients that underwent surgery were observed
before the surgical procedure and three months later, one
of them had CMI alone and the other two had CMI and
syringomyelia; any significant reduction in RNFL thickness
was observed.
4. Discussion
OCT images of the optic nerve head and analysis of the mean
RNFL thickness associated with the mean thickness value of
the four quadrants allowed detailed quantitative description
of the peripapillary RNFL. We observed a reduction of the
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Table 2: CMI patients (Group A) versus healthy subject (Group C) OCT parameters, LE.
Variables Average (휇) Average (휇) 푃 value
Standard deviation Group A Standard deviation Group C
RNFL 98,563 (10,09) 98,563 (10,099) 0.007∗
Superior quadrant 119,688 (16,756) 127,438 (15,900) 0.035∗∗
Subfield 11 121,500 (38,346) 131,375 (26,051) 0.800
Subfield 12 125,688 (23,431) 124,125 (19,280) 0.838
Subfield 1 107,125 (16,721) 126,813 (25,079) 0.014∗
Temporal quadrant 65,813 (10,381) 85,563 (10,381) 0.0003∗
Subfield 2 74,375 (11,960) 95,875 (16,358) 0.0002∗
Subfield 3 52,750 (9,356) 74,375 (18,319) 0.0002∗
Subfield 4 70,188 (13,905) 85,500 (19,375) 0.017∗
Inferior quadrant 118,813 (14,616) 134,938 (20,780) 0.017∗
Subfield 5 131,438 (22,091) 142,313 (28,109) 0.233
Subfield 6 124,063 (26,839) 147,188 (35,309) 0.046∗
Subfield 7 101,625 (18,446) 115,875 (36,138) 0.170
Nasal quadrant 89,250 (25,104) 93,188 (21,097) 0.454
Subfield 8 79,688 (25,742) 88,750 (18,109) 0.259
Subfield 9 75,625 (22,295) 80,250 (19,797) 0.540
Subfield 10 111,563 (32,356) 104,250 (39,079) 0.569
RNFL: retinal nerve fiber layer thickness in 휇.
Group A: patient with CMI.
Group C: healthy subjects.
1–12: three subfields for each quadrant numbered clockwise.∗푃 < 0.05, 푡-test.∗∗푃 < 0.05, Mann-Whitney 푈 test.
Table 3: CMI patients with syringomyelia (Group B) versus healthy subject (Group D) OCT parameters, RE.
Variables Average (휇) Average (휇) 푃 value
Standard deviation Group A Standard deviation Group C
RNFL 112,667 (7,633) 115,500 (19,024) 0.742
Superior quadrant 141,500 (7,503) 125,333 (12,754) 0.023∗
Subfield 11 135,000 (28,921) 142,500 (27,406) 0.655
Subfield 12 143,667 (30,716) 128,833 (20,124) 0.346
Subfield 1 146,500 (22,801) 105,167 (8,841) 0.002∗
Nasal quadrant 106,333 (28,444) 100,833 (27,140) 0.739
Subfield 2 118,167 (31,600) 104,667 (27,580) 0.449
Subfield 3 90,000 (22,821) 88,500 (26,614) 0.919
Subfield 4 109,667 (31,085) 109,833 (33,891) 0.993
Inferior quadrant 120,667 (14,137) 140,167 (24,975) 0.127
Subfield 5 109,333 (28,338) 138,000 (36,546) 0.160
Subfield 6 124,500 (24,023) 144,333 (38,609) 0.310
Subfield 7 127,667 (18,705) 138,667 (29,371) 0.457
Temporal quadrant 80,000 (28,213) 95,333 (29,351) 0.378
Subfield 8 86,000 (39,115) 92,667 (24,328) 0.730
Subfield 9 68,333 (21,267) 91,833 (44,256) 0.069
Subfield 10 86,167 (27,817) 102,000 (24,380) 0.319
RNFL: retinal nerve fiber layer thickness in 휇.
1–12: three subfields for each quadrant numbered clockwise.
Group B: CMI patient’s with syringomyelia.
Group D: healthy subjects.∗푃 < 0.05, 푡-test.
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Table 4: CMI patients with syringomyelia (Group B) versus healthy subject (Group D) OCT parameters, LE.
Variables Average (휇) Average (휇) 푃 value
Standard deviation Group A Standard deviation Group C
RNFL 107,667 (8,287) 108,000 (10,770) 0.953
Superior quadrant 116,333 (12,972) 128,167 (13,152) 0.148
Subfield 11 138,500 (24,263) 132,333 (21,172) 0.649
Subfield 12 111,167 (21,830) 122,500 (18,641) 0.356
Subfield 1 99,333 (19,906) 129,667 (14,501) 0.013∗
Temporal quadrant 68,667 (16,549) 88,500 (13,664) 0.047∗
Subfield 2 76,333 (27,478) 95,000 (15,192) 0.176
Subfield 3 58,167 (17,116) 76,667 (23,441) 0.150
Subfield 4 71,000 (8,246) 93,833 (15,433) 0.010∗
Inferior quadrant 134,500 (14,139) 128,667 (19,242) 0.563
Subfield 5 142,833 (26,828) 148,333 (28,794) 0.739
Subfield 6 148,500 (11,777) 134,667 (31,747) 0.341
Subfield 7 112,333 (24,712) 103,167 (18,946) 0.487
Nasal quadrant 106,833 (29,668) 86,833 (12,287) 0.060
Subfield 8 103,167 (28,435) 81,833 (15,562) 0.138
Subfield 9 100,500 (32,042) 76,500 (8,361) 0.030∗∗
Subfield 10 116,500 (34,309) 102,333 (15,744) 0.700
RNFL: retinal nerve fiber layer thickness in 휇.
1–12: three subfields for each quadrant numbered clockwise.
Group B: CMI patient’s with syringomyelia.
Group D: healthy subjects.∗푃 < 0.05, 푡-test.∗∗푃 < 0.05, Mann-Whitney 푈 test.
mean RNFL thickness in CMI patients when compared to
healthy controls, but this reduction is lower if we consider
CMI patients with syringomyelia and surgical patients with
CMI. Probably it could be related to the papilloedema
more frequently observed in patients with syringomyelia and
surgical patients with CMI, as previously documented in
literature [6, 7]. This is an explorative study; for this reason
we decided to consider separately the two eyes and not to
randomize only one eye. Looking at the results LE seems
more severely affected than the right one, but CMI is a
central condition and we expected to find any difference
between the eyes. Looking at the published literature [7–10]
a different involvement of the eyes is described; particularly
papilloedema seems greater in one eye than in the other.
Further larger studies are necessary to confirm if there could
be a difference between the eyes and if this difference is
significant when compared with the controls.
Zhang et al. [6] described in their paper the case
of a woman with symptomatic CMI and papilloedema,
OCT documented, and treated surgically with suboccipital
decompression. After surgery the patient’s visual symptoms
improved but a residual bilateral optic nerve atrophy was
observed. In fact, it is crucial to differentiate CMI and idio-
pathic intracranial hypertension, because of the similarities
in patient’s presentation [6, 14]. Bilateral optic disc oedema
with preserved visual acuity and retinal nerve fiber layer loss
is typically the consequence of papilloedema. And this could
explain the reduction of RNFL observed in our patients.
The pathogenesis of papilloedema in CMI is not clear.
Some authors [2, 7] speculated that posterior fossa crowding
results in cerebrospinal fluid flow delay, causing spikes of
intracranial pressure (ICP) during pressure pulses (Valsalva
maneuvers, etc.). On the other side it is likely that there
exist some structural congenital changes that predispose to
development of papilloedema.This could explain why not all
CMI patients, independently from the cerebellar morphol-
ogy, have a papilloedema. It is likely that even if the edema is
not visible the chronic tonsilar herniation determines nerves
fiber suffering that justifies a thinner RNFL in CMI patient
than healthy subjects. But this could also explain why this
difference is less when syrinx is associated with CMI. This
group of patients showed a thicker optic nerve head probably
due to an oedema of the ONH.
Vaphiades et al. [7] described a case series of four patients
with CMI successfully treated with suboccipital decompres-
sion.The authors stated that the primary role of neuroimag-
ing in patients with papilloedema is to exclude hydrocephalus
and disorders that cause increased ICP, particularly space-
occupying lesions and cerebral venous thromboses.They also
concluded that in their experience posterior fossa decom-
pression can be curative in patients with increased ICP and
papilloedema caused byCMI. In our series only three patients
underwent suboccipital decompression. All of them showed
a papilloedema but looking at the RNFL thickness three
months after surgery any significant reduction was observed.
Probably the three-month ophthalmological evaluation was
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too early to identify a modification. Two of the patients
presented CMI associated with syringomyelia, so in Group
B two of the 6 patients underwent decompression and this
could represent a statistical bias, but we decide not to exclude
them from the comparison with healthy controls because this
is an explorative study and we try to obtain as much as we can
from the analysis.
Recent OCT studies in neuroophthalmological diseases
[15–17] like multiple sclerosis (MS) or Parkinson’s disease
showed a reduction of the RNFL thickness; Pulicken et al.
[15] observe that RNFL is significantly decreased in multiple
sclerosis optic neuritis (ON) eyes, unaffected fellow eyes of
patients with MS ON, and MS eyes not affected by ON.This
has suggested that chronic axon damage can occur in MS
eyes distinct from acute ON episodes. They also observed
that subclinical ON could also damage axons in progressive
forms of MS. These findings could be explained either by a
subclinical ongoing inflammation or by neuronal cell death.
CMI as MS is a chronic condition that could lead to neuronal
cell death and axons damage.
Schild et al. [16] described a reduction of the RNFL
thickness as well as ganglion cell layer (GCL) in patients with
autosomal dominant optic atrophy using spectral domain
OCT (SDOCT) images, especially in the inferior and superior
peripapillary quadrants.The authors concluded that SDOCT
volume scans could be important to diagnose a loss of
vision of unclear origin but also to see the effects of future
therapies. Equally in CMI patients, OCT could represent an
examination to quantify the ONH oedema and to follow the
patients after surgery besides neuroimaging. Equally Feng
et al. [17] demonstrated in Chinese people with MS the
thinning of RNFLwith SDOCT and they suggested the use of
the tomography as a high-resolution, objective, noninvasive,
and easily quantifiable in vivo biomarker of MS. OCT is a
rapid high-resolution method to obtain morphological and
quantitative information that could be important in theman-
agement and follow-up of patients with neurodegenerative
diseases such as CMI or SM. At least looking at the studies
of Garcia-Martin and her research group in Saragoza [18, 19],
we obtain a confirmation of what we have already discussed
for MS, because the analysis based on the segmentation
technologies of the Spectralis OCT (Heidelberg Engineering,
Inc., Heidelberg, Germany) showed retinal layer atrophy in
patientswithMS, especially of the inner layers.They observed
also the reduction of the ganglion cell and inner plexiform
layer as predictor of greater axonal damage. The Spanish
group study [19] observed also with the same technique
Parkinson’s disease and SDOCT revealed retinal layer atrophy
especially in patients with longer duration disease.
One limitation of this study is that we consider a small
study group, but CMI is a rare disease. Although this is
unlikely to affect the results, it may introduce a possible
bias in the study. In addition, it is possible that some
individuals with low-tension glaucomawere included in both
groups (CMI and controls), which may have biased the find-
ings. Considering the not statistically significant difference
between pre- and postsuboccipital decompression, the short
time (only threemonths) follow-up could explain our results.
Further studies are needed to confirm our findings and to
determine whether there could be a difference between the
four quadrants of the optic nerve head or if there could be a
difference between eyes.
In conclusion OCT of the optic nerve head in CMI
patients represents a reproducible, noninvasive, high speed,
and high-resolution instrument that can add useful informa-
tion for the treatment of these patients. OCT measurements
are tools that can be used in combination with other param-
eters and clinical explorations such as neuroimages.
This technique may further be important also for the
documentation of possible future therapies and for the
follow-up of nonsurgical patients tomonitor the chronic fiber
suffering and axon cell death through the thinning of the
RNFL in a long-term follow-up time.
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